Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Horowitz

Showing results (61-70 of 219) with videos related to

Pageof 22
Sort By:
Journal of Hypertension|September 14, 2004
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulationDuncan J Campbell, Christopher J Zeitz, Murray D Esler, et al.
American Heart Journal|July 10, 2003
Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenonJohn F Beltrame, Sananand B Limaye, Ronald D Wuttke, et al.
European Journal of Pharmacology|February 13, 2007
Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectorisElizabeth A Liberts, Scott R Willoughby, Jennifer A Kennedy, et al.
The American Journal of Cardiology|February 12, 2002
Resolution of ST-segment elevation following intravenous administration of nitroglycerin and verapamilJohn F Beltrame, Simon Stewart, Susan Leslie, et al.
The American Journal of Cardiology|May 29, 2004
Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunctionYuliy Y Chirkov, Andrew S Holmes, Jason D Martelli, et al.
Acute Cardiac Care|July 9, 2008
Is there still a role for treatment with beta-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?John D Horowitz, Margaret A Arstall, Christopher J Zeitz, et al.
Current Opinion in Cardiology|June 11, 2010
Modulation of myocardial metabolism: an emerging therapeutic principleJohn D Horowitz, Yuliy Y Chirkov, Jennifer A Kennedy, et al.
Expert Review of Clinical Pharmacology|September 12, 2022
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment optionsGao Jing Ong, Thanh Ha Nguyen, Sven Y Surikow, et al.
Heart, Lung & Circulation|November 30, 2014
Reply: Takotsubo syndrome is a systemic, rather than merely a cardiac, disease: possible effects on the systemic and pulmonary vasculatureKuljit Singh, Cher-Rin Chong, Thanh H Nguyen, et al.
Heart, Lung & Circulation|January 31, 2012
Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitorsChristopher J A Neil, Cher-Rin Chong, Thanh H Nguyen, et al.
Pageof 22

Showing results (61-70 of 219) with videos related to

Sort By:
Pageof 22
Journal of Hypertension|September 14, 2004
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulationDuncan J Campbell, Christopher J Zeitz, Murray D Esler, et al.
American Heart Journal|July 10, 2003
Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenonJohn F Beltrame, Sananand B Limaye, Ronald D Wuttke, et al.
European Journal of Pharmacology|February 13, 2007
Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectorisElizabeth A Liberts, Scott R Willoughby, Jennifer A Kennedy, et al.
The American Journal of Cardiology|February 12, 2002
Resolution of ST-segment elevation following intravenous administration of nitroglycerin and verapamilJohn F Beltrame, Simon Stewart, Susan Leslie, et al.
The American Journal of Cardiology|May 29, 2004
Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunctionYuliy Y Chirkov, Andrew S Holmes, Jason D Martelli, et al.
Acute Cardiac Care|July 9, 2008
Is there still a role for treatment with beta-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?John D Horowitz, Margaret A Arstall, Christopher J Zeitz, et al.
Current Opinion in Cardiology|June 11, 2010
Modulation of myocardial metabolism: an emerging therapeutic principleJohn D Horowitz, Yuliy Y Chirkov, Jennifer A Kennedy, et al.
Expert Review of Clinical Pharmacology|September 12, 2022
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment optionsGao Jing Ong, Thanh Ha Nguyen, Sven Y Surikow, et al.
Heart, Lung & Circulation|November 30, 2014
Reply: Takotsubo syndrome is a systemic, rather than merely a cardiac, disease: possible effects on the systemic and pulmonary vasculatureKuljit Singh, Cher-Rin Chong, Thanh H Nguyen, et al.
Heart, Lung & Circulation|January 31, 2012
Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitorsChristopher J A Neil, Cher-Rin Chong, Thanh H Nguyen, et al.
Pageof 22